Literature DB >> 14310348

FAILURE OF DEXTROAMPHETAMINE SULFATE TO INFLUENCE EATING AND SLEEPING PATTERNS IN OBESE SCHIZOPHRENIC PATIENTS: CLINICAL AND PHARMACOLOGICAL SIGNIFICANCE.

W MODELL, A E HUSSAR.   

Abstract

Entities:  

Keywords:  APPETITE; BLOOD PRESSURE; DEXTRO AMPHETAMINE; DRUG THERAPY; OBESITY; PULSE; SCHIZOPHRENIA; SLEEP

Mesh：

Substances：

Year:  1965        PMID： 14310348     DOI： 10.1001/jama.1965.03090040019006

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  11 in total

Review 1.  Management of antipsychotic-related weight gain.

Authors:  Lawrence Maayan; Christoph U Correll
Journal:  Expert Rev Neurother       Date:  2010-07       Impact factor: 4.618

Review 2.  Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis.

Authors:  Lawrence Maayan; Julia Vakhrusheva; Christoph U Correll
Journal:  Neuropsychopharmacology       Date:  2010-03-24       Impact factor: 7.853

Review 3.  Interventions to reduce weight gain in schizophrenia.

Authors:  G Faulkner; T Cohn; G Remington
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

4.  Room to move: Plasticity in early auditory information processing and auditory learning in schizophrenia revealed by acute pharmacological challenge.

Authors:  Neal R Swerdlow; Savita G Bhakta; Gregory A Light
Journal:  Schizophr Res       Date:  2018-04-05       Impact factor: 4.939

5.  Interventions for the metabolic syndrome in schizophrenia: a review.

Authors:  Evangelos Papanastasiou
Journal:  Ther Adv Endocrinol Metab       Date:  2012-10       Impact factor: 3.565

Review 6.  Pharmacological strategies to counteract antipsychotic-induced weight gain and metabolic adverse effects in schizophrenia: a systematic review and meta-analysis.

Authors:  Yuya Mizuno; Takefumi Suzuki; Atsuo Nakagawa; Kazunari Yoshida; Masaru Mimura; Walter Wolfgang Fleischhacker; Hiroyuki Uchida
Journal:  Schizophr Bull       Date:  2014-03-17       Impact factor: 9.306

Review 7.  On certain psychopharmacological and physiological differences between schizophrenic and normal persons.

Authors:  C Kornetsky; A F Mirsky
Journal:  Psychopharmacologia       Date:  1966

8.  Amphetamine Enhances Gains in Auditory Discrimination Training in Adult Schizophrenia Patients.

Authors:  Neal R Swerdlow; Melissa Tarasenko; Savita G Bhakta; Jo Talledo; Alexis I Alvarez; Erica L Hughes; Brinda Rana; Sophia Vinogradov; Gregory A Light
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

9.  Provocative tests with psychostimulant drugs in schizophrenia.

Authors:  J A Lieberman; J M Kane; J Alvir
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

10.  Effects of Amphetamine on Sensorimotor Gating and Neurocognition in Antipsychotic-Medicated Schizophrenia Patients.

Authors:  Neal R Swerdlow; Savita G Bhakta; Jo A Talledo; Daniel M Franz; Erica L Hughes; Brinda K Rana; Gregory A Light
Journal:  Neuropsychopharmacology       Date:  2017-11-20       Impact factor: 7.853
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.